Giulianotti Pier Cristoforo, Coratti Andrea, Angelini Marta, Sbrana Fabio, Cecconi Simone, Balestracci Tommaso, Caravaglios Giuseppe
Department of General Surgery, Misericordia Hospital, Grosseto, Italy.
Arch Surg. 2003 Jul;138(7):777-84. doi: 10.1001/archsurg.138.7.777.
HYPOTHESIS: Robotic technology is the most advanced development of minimally invasive surgery, but there are still some unresolved issues concerning its use in a clinical setting. DESIGN: The study describes the clinical experience of the Department of General Surgery, Misericordia Hospital, Grosseto, Italy, in robot-assisted surgery using the da Vinci Surgical System. RESULTS: Between October 2000 and November 2002, 193 patients underwent a minimally invasive robotic procedure (74 men and 119 women; mean age, 55.9 years [range, 16-91 years]). A total of 207 robotic surgical operations, including abdominal, thoracic and vascular procedures, were performed; 179 were single procedures, and 14 were double (2 operations on the same patient). There were 4 conversions to open surgery and 3 to conventional laparoscopy (conversion rate, 3.6%; 7 of 193 patients). The perioperative morbidity rate was 9.3% (18 of 193 patients), and 6 patients (3.1%) required a reoperation. The postoperative mortality rate was 1.5% (3 of 193 patients). CONCLUSIONS: Our preliminary experience at a large community hospital suggests that robotic surgery is feasible in a clinical setting. Its daily use is safe and easily managed, and it expands the applications of minimally invasive surgery. However, the best indications still have to be defined, and the cost-benefit ratio must be evaluated. This report could serve as a basis for a future prospective, randomized trial.
假设:机器人技术是微创手术最先进的发展成果,但在临床应用中仍存在一些未解决的问题。 设计:本研究描述了意大利格罗塞托米塞里科迪亚医院普通外科在使用达芬奇手术系统进行机器人辅助手术方面的临床经验。 结果:2000年10月至2002年11月期间,193例患者接受了微创机器人手术(74例男性和119例女性;平均年龄55.9岁[范围16 - 91岁])。共进行了207例机器人外科手术,包括腹部、胸部和血管手术;179例为单台手术,14例为两台手术(同一患者进行2次手术)。有4例转为开放手术,3例转为传统腹腔镜手术(转化率3.6%;193例患者中的7例)。围手术期发病率为9.3%(193例患者中的18例),6例患者(3.1%)需要再次手术。术后死亡率为1.5%(193例患者中的3例)。 结论:我们在一家大型社区医院的初步经验表明,机器人手术在临床环境中是可行的。其日常使用安全且易于管理,并且扩展了微创手术的应用范围。然而,最佳适应症仍有待确定,且必须评估成本效益比。本报告可作为未来前瞻性随机试验的基础。
Ann Thorac Surg. 2004-7
Eur Urol. 2009-5
J Minim Invasive Gynecol. 2009
Chir Ital. 2006
Hepatobiliary Surg Nutr. 2025-8-1
ILIVER. 2022-10-11